These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 16251774)
1. Optimizing treatment in head and neck cancers -- are molecular markers the answer? D'cruz AK; Mulherkar R Indian J Med Res; 2005 Sep; 122(3):196-8. PubMed ID: 16251774 [No Abstract] [Full Text] [Related]
2. Role of molecular markers in the management of head and neck cancers. Ferreira MB; De Souza JA; Cohen EE Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329 [TBL] [Abstract][Full Text] [Related]
3. Molecular markers in the head and neck cancers: are we there yet? Rath GK J Cancer Res Ther; 2013; 9(1):1-2. PubMed ID: 23575064 [No Abstract] [Full Text] [Related]
4. [Molecular markers of head and neck cancer]. Temam S; Janot F Rev Prat; 2006 Oct; 56(15):1658-61. PubMed ID: 17137250 [TBL] [Abstract][Full Text] [Related]
5. Tumor markers of head and neck carcinoma. Eibling DE; Wagner RL; Johnson JT Immunol Ser; 1990; 53():357-83. PubMed ID: 2100567 [TBL] [Abstract][Full Text] [Related]
6. Oncogenes, molecular biology and the head and neck surgeon. Irish JC J Otolaryngol; 1992 Dec; 21 Suppl 3():1-20. PubMed ID: 1289578 [TBL] [Abstract][Full Text] [Related]
7. Salivary gland carcinomas, paranasal sinus cancers and melanoma of the head and neck: an update about rare but challenging tumors. Lalami Y; Vereecken P; Dequanter D; Lothaire P; Awada A Curr Opin Oncol; 2006 May; 18(3):258-65. PubMed ID: 16552238 [TBL] [Abstract][Full Text] [Related]
8. Is there a role for selective neck dissection after chemoradiation for head and neck cancer? Robbins KT; Ferlito A; Suárez C; Brizel DM; Bradley PJ; Pellitteri PK; Clayman GL; Kowalski LP; Genden EM; Rinaldo A J Am Coll Surg; 2004 Dec; 199(6):913-6. PubMed ID: 15555975 [No Abstract] [Full Text] [Related]
9. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck. Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in head and neck oncology: a critical appraisal for use in clinical practice. Chiesa F; Tradati N; Mauri S; Calabrese L; Grigolato R; Giugliano G; Zurrida S; Chiesa E; Squadrelli M; Viale G; Maiorano E Anticancer Res; 1998; 18(6B):4769-76. PubMed ID: 9891555 [TBL] [Abstract][Full Text] [Related]
11. Oral mucositis in cancer therapy. Sonis ST J Support Oncol; 2004; 2(6 Suppl 3):3-8. PubMed ID: 15605918 [TBL] [Abstract][Full Text] [Related]
12. Incorporation of molecularly targeted agents in the primary treatment of squamous cell carcinomas of the head and neck. Bernier J Hematol Oncol Clin North Am; 2008 Dec; 22(6):1193-208, ix. PubMed ID: 19010268 [TBL] [Abstract][Full Text] [Related]
13. Is gene expression profiling of head and neck cancers ready for the clinic? Ziober AF; D'Alessandro L; Ziober BL Biomark Med; 2010 Aug; 4(4):571-80. PubMed ID: 20701444 [TBL] [Abstract][Full Text] [Related]
14. Hypoxia in head and neck cancer: how much, how important? Janssen HL; Haustermans KM; Balm AJ; Begg AC Head Neck; 2005 Jul; 27(7):622-38. PubMed ID: 15952198 [TBL] [Abstract][Full Text] [Related]
15. [The effect of the microenvironment of head and neck cancers on tumor progression]. Lukits J Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327 [TBL] [Abstract][Full Text] [Related]
16. [Galectins in squamous cell carcinomas of the head and neck cancers]. Cada Z; Plzák J; Chovanec M; Dvoránková B; Lacina L; Szabó P; Smetana K; Betka J Cas Lek Cesk; 2008; 147(11):559-63. PubMed ID: 19097359 [TBL] [Abstract][Full Text] [Related]
17. Radiation oncologists work to protect patients' oral health: in the process, researchers also make strides in treating head and neck cancers. Printz C Cancer; 2012 Jul; 118(13):3223-4. PubMed ID: 22711572 [No Abstract] [Full Text] [Related]
18. Nutritional concepts in the management of the head and neck cancer patient. I. Basic concepts. Sobol SM; Conoyer JM; Zill R; Thawley SE; Ogura JH Laryngoscope; 1979 May; 89(5 Pt 1):794-803. PubMed ID: 109712 [TBL] [Abstract][Full Text] [Related]
19. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck. Eibling DE; Johnson JT; Wagner RL; Su S Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421 [TBL] [Abstract][Full Text] [Related]
20. Multiple cytokine and growth factor serum biomarkers predict therapeutic response and survival in advanced-stage head and neck cancer patients. Bigbee WL; Grandis JR; Siegfried JM Clin Cancer Res; 2007 Jun; 13(11):3107-8. PubMed ID: 17545511 [No Abstract] [Full Text] [Related] [Next] [New Search]